StockData
CME Group Inc. logo

CME Group Inc. (CME) stock

CMENasdaqSecurity & Commodity Brokers, Dealers, Exchanges & ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 10/3018% above fair value
$310.25−1.31 (-0.42%)

Close on Nov 18, 2026Market cap $111.05BP/E 25.5Yield 1.61%

CME revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

CME's revenue for the twelve months ending Sep 30, 2026 was $6.97B, up 9.0% year over year. For fiscal 2025 it was $6.52B, up 6.4% from the year before. Over ten years it grew 7.0% a year on average. The highest annual figure on record is $6.52B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.52B+6.4%
FY2024Dec 31, 2024$6.13B+9.9%
FY2023Dec 31, 2023$5.58B+11.1%
FY2022Dec 31, 2022$5.02B+7.0%
FY2021Dec 31, 2021$4.69B-4.0%
FY2020Dec 31, 2020$4.88B+0.3%
FY2019Dec 31, 2019$4.87B+13.0%
FY2018Dec 31, 2018$4.31B+18.2%
FY2017Dec 31, 2017$3.64B+1.4%
FY2016Dec 31, 2016$3.60B+8.1%
FY2015Dec 31, 2015$3.33B+6.9%
FY2014Dec 31, 2014$3.11B+6.0%
FY2013Dec 31, 2013$2.94B+0.7%
FY2012Dec 31, 2012$2.91B-11.2%
FY2011Dec 31, 2011$3.28B+9.2%
FY2010Dec 31, 2010$3.00B+15.0%
FY2009Dec 31, 2009$2.61B+2.0%
FY2008Dec 31, 2008$2.56B+45.8%
FY2007Dec 31, 2007$1.76B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.74B+13.0%
Q2 FY2026Jun 30, 2026$1.71B+0.8%
Q1 FY2026Mar 31, 2026$1.88B+14.5%
Q4 FY2025Dec 31, 2025$1.65B+8.1%
Q3 FY2025Sep 30, 2025$1.54B-3.0%
Q2 FY2025Jun 30, 2025$1.69B+10.4%
Q1 FY2025Mar 31, 2025$1.64B+10.4%
Q4 FY2024Dec 31, 2024$1.53B+6.0%
Q3 FY2024Sep 30, 2024$1.58B+18.4%
Q2 FY2024Jun 30, 2024$1.53B+12.7%
Q1 FY2024Mar 31, 2024$1.49B+3.2%
Q4 FY2023Dec 31, 2023$1.44B+19.2%
Q3 FY2023Sep 30, 2023$1.34B+9.0%
Q2 FY2023Jun 30, 2023$1.36B+9.9%
Q1 FY2023Mar 31, 2023$1.44B+7.1%
Q4 FY2022Dec 31, 2022$1.21B+5.3%
Q3 FY2022Sep 30, 2022$1.23B+10.6%
Q2 FY2022Jun 30, 2022$1.24B+4.9%
Q1 FY2022Mar 31, 2022$1.35B+7.4%
Q4 FY2021Dec 31, 2021$1.15B+4.4%
Q3 FY2021Sep 30, 2021$1.11B+2.7%
Q2 FY2021Jun 30, 2021$1.18B-0.3%
Q1 FY2021Mar 31, 2021$1.25B-17.7%
Q4 FY2020Dec 31, 2020$1.10B-3.5%
Q3 FY2020Sep 30, 2020$1.08B-15.4%
Q2 FY2020Jun 30, 2020$1.18B-7.1%
Q1 FY2020Mar 31, 2020$1.52B+29.0%
Q4 FY2019Dec 31, 2019$1.14B-7.9%
Q3 FY2019Sep 30, 2019$1.28B+41.3%
Q2 FY2019Jun 30, 2019$1.27B+20.1%
Q1 FY2019Mar 31, 2019$1.18B+6.4%
Q4 FY2018Dec 31, 2018$1.24B+37.4%
Q3 FY2018Sep 30, 2018$904.20M+1.5%
Q2 FY2018Jun 30, 2018$1.06B+14.6%
Q1 FY2018Mar 31, 2018$1.11B+19.3%
Q4 FY2017Dec 31, 2017$900.00M-1.4%
Q3 FY2017Sep 30, 2017$890.80M–
Q2 FY2017Jun 30, 2017$924.60M–
Q1 FY2017Mar 31, 2017$929.30M–
Q4 FY2016Dec 31, 2016$912.90M–

More CME figures

See a number that looks wrong?